Phosphorylated FADD induces NF-kappaB, perturbs cell cycle, and is associated with poor outcome in lung adenocarcinomas
about
Oncogenic Ras and B-Raf proteins positively regulate death receptor 5 expression through co-activation of ERK and JNK signalingRegulation of protein kinase C inactivation by Fas-associated protein with death domainFADD protein release mirrors the development and aggressiveness of human non-small cell lung cancerA novel kinase inhibitor of FADD phosphorylation chemosensitizes through the inhibition of NF-κBDED or alive: assembly and regulation of the death effector domain complexesRole of apoptosis in diseaseMinnelide: a novel therapeutic that promotes apoptosis in non-small cell lung carcinoma in vivoEffect of cocaine on Fas-associated protein with death domain in the rat brain: individual differences in a model of differential vulnerability to drug abuseNF-kappaB in lung cancer, a carcinogenesis mediator and a prevention and therapy targetCyclin D1 and FADD as biomarkers in head and neck squamous cell carcinoma.Identification of inhibitors using a cell-based assay for monitoring Golgi-resident protease activity.Inhibition of furin/proprotein convertase-catalyzed surface and intracellular processing by small molecules.Biomarkers of apoptosis and survival in esophageal squamous cell carcinomaInteraction of double-stranded RNA-dependent protein kinase (PKR) with the death receptor signaling pathway in amyloid beta (Abeta)-treated cells and in APPSLPS1 knock-in miceThe role of FADD in pancreatic cancer cell proliferation and drug resistancePrognostic significance of TMEM16A, PPFIA1, and FADD expression in invasive ductal carcinoma of the breastCurcumin promotes apoptosis, increases chemosensitivity, and inhibits nuclear factor kappaB in esophageal adenocarcinoma.Expression of serine 194-phosphorylated Fas-associated death domain protein correlates with proliferation in B-cell non-Hodgkin lymphomas.Increased Expression of Phosphorylated FADD in Anaplastic Large Cell and Other T-Cell Lymphomas.Understanding the Role of the Death Receptor 5/FADD/caspase-8 Death Signaling in Cancer MetastasisHigh-throughput molecular imaging for the identification of FADD kinase inhibitors.Phosphorylation of FADD by the kinase CK1α promotes KRASG12D-induced lung cancer.Epstein-Barr virus (EBV) latent membrane protein-1 down-regulates tumor necrosis factor-alpha (TNF-alpha) receptor-1 and confers resistance to TNF-alpha-induced apoptosis in T cells: implication for the progression to T-cell lymphoma in EBV-associatNF-κB signaling is essential for resistance to heat stress-induced early stage apoptosis in human umbilical vein endothelial cellsClinical Implications of FADD Gene Amplification and Protein Overexpression in Taiwanese Oral Cavity Squamous Cell Carcinomas.FADD regulates thymocyte development at the β-selection checkpoint by modulating Notch signaling.MK2 controls the level of negative feedback in the NF-kappaB pathway and is essential for vascular permeability and airway inflammation.Cortactin expression predicts poor survival in laryngeal carcinomaPrognostic impact of Fas-associated death domain, a key component in death receptor signaling, is dependent on the presence of lymph node metastasis in head and neck squamous cell carcinomaThe DUSP26 phosphatase activator adenylate kinase 2 regulates FADD phosphorylation and cell growth.Deregulated FADD expression and phosphorylation in T-cell lymphoblastic lymphoma.The TRAIL-Induced Cancer Secretome Promotes a Tumor-Supportive Immune Microenvironment via CCR2.The 11q13-q14 amplicon: clinicopathological correlations and potential drivers.SMAC Mimetic Birinapant plus Radiation Eradicates Human Head and Neck Cancers with Genomic Amplifications of Cell Death Genes FADD and BIRC2.FADD phosphorylation impaired islet morphology and function.Some findings of FADD knockdown in inhibition of HIV-1 replication in Jurkat cells and PBMCs.Comparative proteomics analysis reveals roles for FADD in the regulation of energy metabolism and proteolysis pathway in mouse embryonic fibroblast.Functional specific roles of FADD: comparative proteomic analyses from knockout cell lines.Phosphatidylinositol 3-kinase/Akt signaling mediates interleukin-6 protection against p53-induced apoptosis in M1 myeloid leukemic cells.Temporal Identification of Dysregulated Genes and Pathways in Clear Cell Renal Cell Carcinoma Based on Systematic Tracking of Disrupted Modules
P2860
Q24296451-0B798B7C-0E00-46EA-AB87-1718DBA5F47BQ24629012-05B84037-109D-4C8A-A865-B48DEE165631Q24634052-C5812F7A-A7AA-4F06-86A8-786EAACB2178Q24635114-4442B19C-AC91-48C1-BA44-C604D23DAB9BQ26796544-33489907-769B-4212-82C8-1EEF88369BE5Q26865637-4B3312BD-D224-4D0A-8F94-35534CE814CEQ27303920-6E2E745B-1659-409D-9142-A8566D36AAD5Q28574580-A3021384-A673-4CA9-B530-E3DB805B0245Q28611413-4953504A-DEC6-4E9D-A6C0-C628994CD268Q30455091-DEC7ABD1-81F0-473B-9C9C-C4538DB5625FQ33275047-AA4EA9C5-B984-4E75-AE8C-BD61827871B1Q33424237-AA85B3D3-67EA-4737-8371-0850D834BBDEQ33499881-0D1395F2-A9F4-4C79-9963-DE50AC392498Q33569701-D46CEB81-7971-41A3-8DF1-DCF660D5D8BEQ33598878-79541B23-91E0-4E31-A474-FF8ABB8131ABQ33637350-101BB66C-8C31-48B7-91A3-99FA3C1A3453Q33760596-B3731795-02E7-4726-AA70-0A6D38AC4C00Q33873985-32A0ECF0-BBFB-435A-AAD2-8F0F64F8F5E0Q34156334-FA666511-6937-4924-888A-C23E571C1DC5Q34731599-711260D0-146E-4955-A4A5-A1974585DD75Q35026099-2C7AD877-A001-4012-92C4-2EE55A0515BAQ35559013-1B95F84E-04AE-4C64-B49D-15CC4E04D537Q35757197-E11AA317-D2FB-4596-9975-58A180CA07E3Q36026714-3B6D00EE-1D50-4E5E-B40C-6C8E9E54A5F2Q36169254-84BE9E54-6622-4383-AFDE-ACDD0803CA2CQ36179534-3844D42C-18A3-4179-883E-61B1C132A224Q36229545-205B49A7-A662-4481-BCC4-B374B035D096Q36494166-7777D33B-73DA-44A6-86D5-443C8BABB758Q36887771-BEFAF2D2-F683-4572-95E4-0D2215A64434Q37628292-E5F3343E-9A78-4FFB-8B50-317D0A1C643AQ37641627-0268014A-E2C8-4BC3-8BB5-70B25311C354Q37651394-D72A3A0E-5008-4B8F-8CCA-16C3E50CBBA2Q38066149-21A0177C-F1CD-4AB5-8637-7A7C57524285Q38755115-DC88B1A3-5BF9-4E1C-A4B6-34A5E9F1512CQ38914203-F011DDA8-5E03-46D9-BB16-FA032F7170B5Q39002317-53B40D8E-3504-4F6C-9CE5-64CADA58682EQ39142808-18A777A4-BDEF-412D-8371-DC73FD18D8A1Q39149536-B9589BA6-C635-4A35-8BB2-B21A77FC327EQ40209258-88EAEB01-9DA0-4BF6-BB70-B8D433892179Q40349524-28C41558-165A-4D13-BDD4-67091CF15D7F
P2860
Phosphorylated FADD induces NF-kappaB, perturbs cell cycle, and is associated with poor outcome in lung adenocarcinomas
description
2005 nî lūn-bûn
@nan
2005 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Phosphorylated FADD induces NF ...... utcome in lung adenocarcinomas
@ast
Phosphorylated FADD induces NF ...... utcome in lung adenocarcinomas
@en
type
label
Phosphorylated FADD induces NF ...... utcome in lung adenocarcinomas
@ast
Phosphorylated FADD induces NF ...... utcome in lung adenocarcinomas
@en
prefLabel
Phosphorylated FADD induces NF ...... utcome in lung adenocarcinomas
@ast
Phosphorylated FADD induces NF ...... utcome in lung adenocarcinomas
@en
P2093
P2860
P356
P1476
Phosphorylated FADD induces NF ...... utcome in lung adenocarcinomas
@en
P2093
Alnawaz Rehemtulla
Andrew C Heaford
Bharathi Laxman
Brian D Ross
Dafydd G Thomas
Daniel C Chang
David Adams
David G Beer
Guoan Chen
Julia M Coppola
P2860
P304
12507-12512
P356
10.1073/PNAS.0500397102
P407
P577
2005-08-18T00:00:00Z